Vindelov, L.L., "Flow Microfluorometric Analysis of Nuclear DNA in Cells from Solid Tumors and Cells Suspensions," Vichows Arch. B Cell Path. 24:277-242 (1977). |
Sigma Chemical Co. Catalog, St. Louis, MO., 1984, p. 898. |
Robins, M.J. et al., "A Mild Conversion of Vicinal Diols to Alkenes. Efficient Transformation of Ribonucleosides into 2'-Ene and 2',3'-Dideoxynucleosides," Tetrahedron Letters 25:367-370 (1984). |
Saxena, N.K. et al., "Synthesis and Antiviral Activity of Certain 4-Substituted and 2,4-Disubstituted 7-�(2-Hydroxyethoxy)methyl!pyrrolo�2,3-d!pyrimidines," J. Med. Chem. 31:1507-1506 (1988). |
Shipman, Jr., C., "Evaluation of 4-(2-Hydroxyethyl)-1-Piperazineethanesulfonic Acid (HEPES) as a Tissue Culture Buffer," Proc. Sci. Exp. Biol. Med. 120:305-310 (1969). |
Shipman, Jr. C. et al., "Antiviral Activity of Arabinosyladenine and Arabinosylhypoxanthine in Herpes Simplex Virus-Infected KB Cells: Selective Inhibition of Viral Deoxyribonucleic Acid Synthesis in Synchronized Suspension Cultures," Antimicro. Agents Chemother. 9:120-127 (1976). |
Smith, C.M. et al., "Inhibitors of Hypoxanthine Metabolism in Ehrlich Ascites Tumor Cells in Vitro," Can. Treat. Rpts. 60:1567-1584 (1976). |
Tolman, R.L. et al., "Pyrrolopyrimidine Nucleosides. III. The Total Synthesis of Toyocamycin, Sangivamycin, Tubercidin, and Related Derivatives," J. Am. Chem. Soc. 91:2102-2108 (1969). |
Turk, S.R. et al., "Pyrrolo�2,3-d!Pyrimidine Nucleosides as Inhibitors of Human cytomegalovirus," Antimicro. Agents Chemother. 31:544-550 (1987). |
Mitsuya, H. et al., "3'-Azido-3'-deoxythymidine (BW A509U): An Antiviral Agent that Inhibits the Infectivity and Cytopathic Effect of Human T-Lymphotropic Virus Type III/Lymphadenopathy-Associated Virus in Vitro," PNAS (USA) 82:7096-7100 (1985). |
Mitsuya, H. et al., "Inhibition of the in Vitro Infectivity and Cytopathic Effect of Human T-Lymphotrophic Virus Type III/Lymphadenopathy-Associated Virus (HTLV-III/LAV) by 2',3'-Dideoxynucleosides," PNAS (USA) 83:1911-1915 (1986). |
Nassiri, M.R., "3rd Annual Meeting Clinical Applications of Cytometry," Sep. 1988 (Abstract). |
Pudlo, J.S. et al., "Synthesis and Antiviral Activity of Certain 4- and 4,5-Disubstituted 7-�(2-Hydroxyethoxy)Methyl!Pyrrolo�2,3-.sup.d !Pyrimidines," J. Med. Chem. 31:2086-2092 (1988). |
Ramasamy, K. et al., "Total Synthesis of 2'-Depxutpupca,ucom. 2'-Deoxysangivamycin and Related 7-.beta.-D-Arabinofuranosyl-Pyrrolo�2,3-d!Pyrimidines via Ring Closure of Pyrrole Precursors Prepared by the Sterospecific Sodium Salt Glycosylation Procedure," Abstract 65, Tetrahedron, 42(21), (1986), pp. 5869-5878. |
Robins, M.J. et al., "Nucleic Acid Related Compounds. 24 Transformation of Tubercidin 2',3'-O-Orthoacetate into Halo, Deoxy, Epoxide, and Unsaturated Sugar Nucleosides," Can. J. Chem. 55:1251-1259 (1977). |
Drach, J.C., "28 ICAAC, Los Angeles, Calif." Oct. 1988 (Abstract). |
Duffy, T.D. et al., "Pyrrolo�2,3-d!Pyrimidines. Synthesis from 4-Pyrimidylhydrazones, a 2-Bis(Methylthio)Methyleneaminopyrrole-3-Carbonitrile, and a Pyrrolo-�2,3-d!�1,3!Thiazine-2(1H)-Thione," J. Chem. Soc. Perkin Trans. 16:1921-1929 (1974). |
Gadler, H., "Nucleic Acid Hybridization for Measurement of Effects of Antiviral Compounds on Human Cytomegalovirus DNA Replication," Antimicro. Agents Chem. 24:370-374 (1983). |
Gupta, P.K. et al., "Synthesis, Cytotoxicity, and Antiviral Activity of Some Acyclic Analogues of the Pyrrolo�2,3-d!Pyrimidine Nucleoside Antibiotics Tubercidin, Toyocamycin, and Sangivamycin," J. Med. Chem. 32:402-408 (1989). |
Hansske, F. et al., "2' and 3'-Ketonucleosides and Their Arabino and Xylo Reduction Products," Tetrahedron 40:125-135 (1984). |
Jain, T.C. et al., "Reactions of 2-Acyloxyisobutyrl Halides with Nucleosides. II. Reactions of Tubercidin and Formycin," J. Org. Chem. 33:3179-3186 (1973). |
Maruyama T. et al., "Pyrrolopyrimidine Nucleosides. 18..sup.1 Synthesis and Chemotherapeutic Activity of 4-Amino-7-(3-deoxy-.beta.-D-ribofuranosyl)pyrrolo�2,3-d!pyrimidine-5-carboxamide--(3'-Deoxysangivamycin) and 4-Amino-7-(2-deoxy-.beta.-D-ribofuranosyl)pyrrolo�2,3-d!pyrimidine 5-carboxamide (2'-Deoxysangivamycin)," J. Med. Chem 26:25-29 (1983). |
Bergstrom, D.E. et al., "Antiviral Activity of C-5 Substituted Tubercidin Analogues," J. Med. Chem. 27:285-292 (1984). |
De Clercq, E. et al., "Nucleic Acid Related Compounds. 51. Synthesis and Biological Properties of Sugar-Modified Analogues of the Nucleoside Antibiotics Tubercidin, Toyocamycin, Sangivamycin, and Formycin," J. Med. Chem. 30:481-486 (1987). |
De Clercq, E. et al., "Antirhinovirus Activity of Purine Nucleoside Analogs," Antimicro. Agents Chemother. 29:482-487 (1986). |
Drach, J.C. et al., "Tritiated Thymidine Incorporation Does Not Measure DNA Synthesis in Ribavirin-Treated Human Cells," Science 212:549-551 (1981). |